MaxCyte, Inc. Profile Avatar - Palmy Investing

MaxCyte, Inc.

MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; Ex…

Medical - Devices
US, Rockville [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

MaxCyte, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of MXCT's Analysis
CIK: 1287098 CUSIP: - LEI: - UEI: -
Secondary Listings